> Pharmaceutical Litigation > Fen-Phen
Known most commonly as fen-phen, the combination of fenfluramine and phentermine was widely prescribed in the 1990s as a diet drug. By 1996, fen-phen prescriptions topped 6 million. A year later, the drug was pulled from market. But even now people are suffering delayed-onset complications associated with these fen-phen drugs:
Primary pulmonary hypertension (PPH) is a serious lung condition in which the blood pressure in the pulmonary artery is elevated above normal levels. Initial symptoms of PPH include:
The condition must be controlled with drug therapy or a lung transplant. There is no known cure. Progression of the disease may eventually lead to heart failure and death.
Users of fen-phen can be diagnosed with associated PPH and heart-valve disease years after they have stopped taking the drug. No scientific evidence has been found to suggest when the risk of developing PPH subsides after taking fen-phen. In September 2012, a federal judge ruled that there would be no time limit set on lawsuits against Wyeth, now a subsidiary of Pfizer and a former manufacturer of the drug.
If you or a loved one took Fen-Phen and were later diagnosed with PPH, you may be eligible for compensation. The attorneys at the Law Offices of Brian D. Witzer are dedicated to seeking the justice you deserve.
Please contact the Law Offices of Brian D. Witzer by calling (888) WITZER-6 for a free, no-obligation consultation.